214 related articles for article (PubMed ID: 36170757)
21. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study.
Kanayama G; Pope HG; Cohane G; Hudson JI
Drug Alcohol Depend; 2003 Jul; 71(1):77-86. PubMed ID: 12821208
[TBL] [Abstract][Full Text] [Related]
22. Adverse health effects of anabolic-androgenic steroids.
van Amsterdam J; Opperhuizen A; Hartgens F
Regul Toxicol Pharmacol; 2010 Jun; 57(1):117-23. PubMed ID: 20153798
[TBL] [Abstract][Full Text] [Related]
23. [The frequency of formation of a motivated refusal to take androgenic anabolic steroids by men with recreational activity].
Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
Probl Endokrinol (Mosk); 2019 Nov; 65(5):341-350. PubMed ID: 32202738
[TBL] [Abstract][Full Text] [Related]
24. ADHD symptoms and use of anabolic androgenic steroids among male weightlifters.
Kildal E; Hassel B; Bjørnebekk A
Sci Rep; 2022 Jun; 12(1):9479. PubMed ID: 35676515
[TBL] [Abstract][Full Text] [Related]
25. Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes.
Luijkx T; Velthuis BK; Backx FJ; Buckens CF; Prakken NH; Rienks R; Mali WP; Cramer MJ
Int J Cardiol; 2013 Aug; 167(3):664-8. PubMed ID: 22459398
[TBL] [Abstract][Full Text] [Related]
26. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes.
Fyksen TS; Vanberg P; Gjesdal K; von Lueder TG; Bjørnerheim R; Steine K; Atar D; Halvorsen S
Scand J Med Sci Sports; 2022 Aug; 32(8):1170-1181. PubMed ID: 35460300
[TBL] [Abstract][Full Text] [Related]
28. The Availability and Acquisition of Illicit Anabolic Androgenic Steroids and Testosterone Preparations on the Internet.
McBride JA; Carson CC; Coward RM
Am J Mens Health; 2018 Sep; 12(5):1352-1357. PubMed ID: 27170675
[TBL] [Abstract][Full Text] [Related]
29. Anabolic androgenic steroids: a survey of 500 users.
Parkinson AB; Evans NA
Med Sci Sports Exerc; 2006 Apr; 38(4):644-51. PubMed ID: 16679978
[TBL] [Abstract][Full Text] [Related]
30. Impact of androgenic anabolic steroid use on cardiovascular and mental health in Danish recreational athletes: protocol for a nationwide cross-sectional cohort study as a part of the Fitness Doping in Denmark (FIDO-DK) study.
Buhl LF; Lehmann Christensen L; Diederichsen A; Lindholt JS; Kistorp CM; Glintborg D; Andersen M; Frystyk J
BMJ Open; 2024 May; 14(5):e078558. PubMed ID: 38719280
[TBL] [Abstract][Full Text] [Related]
31. Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.
Frati P; Busardò FP; Cipolloni L; Dominicis ED; Fineschi V
Curr Neuropharmacol; 2015 Jan; 13(1):146-59. PubMed ID: 26074749
[TBL] [Abstract][Full Text] [Related]
32. Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review.
Esposito M; Salerno M; Calvano G; Agliozzo R; Ficarra V; Sessa F; Favilla V; Cimino S; Pomara C
Panminerva Med; 2023 Mar; 65(1):43-50. PubMed ID: 35146992
[TBL] [Abstract][Full Text] [Related]
33. [Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users].
Butzke I; Iff S; Zitzmann M; Quednow BB; Claussen MC
Praxis (Bern 1994); 2022 Apr; 111(6):339-344. PubMed ID: 35473320
[TBL] [Abstract][Full Text] [Related]
34. Anabolic androgenic steroid dependence is associated with impaired emotion recognition.
Hauger LE; Sagoe D; Vaskinn A; Arnevik EA; Leknes S; Jørstad ML; Bjørnebekk A
Psychopharmacology (Berl); 2019 Sep; 236(9):2667-2676. PubMed ID: 30941469
[TBL] [Abstract][Full Text] [Related]
35. Exploring Anabolic Androgenic Steroid Use Among Cisgender Gay, Bisexual, and Queer Men.
Kutscher E; Arshed A; Greene RE; Kladney M
JAMA Netw Open; 2024 May; 7(5):e2411088. PubMed ID: 38743422
[TBL] [Abstract][Full Text] [Related]
36. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
[TBL] [Abstract][Full Text] [Related]
37. The relationship between anabolic androgenic steroids and muscle dysmorphia: a review.
Rohman L
Eat Disord; 2009; 17(3):187-99. PubMed ID: 19391018
[TBL] [Abstract][Full Text] [Related]
38. Hidden Danger of Irrational Abusing Illegal Androgenic-anabolic Steroids in Recreational Athletes Age Under 35 in Bosnia & Herzegovina.
Solakovic S; Totic D; Vukas H; Djedovic M
Med Arch; 2015 Jun; 69(3):200-2. PubMed ID: 26261392
[TBL] [Abstract][Full Text] [Related]
39. Anabolic steroid use among gay and bisexual men living in Australia and New Zealand: Associations with demographics, body dissatisfaction, eating disorder psychopathology, and quality of life.
Griffiths S; Murray SB; Dunn M; Blashill AJ
Drug Alcohol Depend; 2017 Dec; 181():170-176. PubMed ID: 29055822
[TBL] [Abstract][Full Text] [Related]
40. Association of Body Dysmorphic-Induced Anabolic-Androgenic Steroid Use With Mental Health Outcomes: A Systematic Review.
Gawash A; Zia H; Al-Shehab U; Lo DF
Prim Care Companion CNS Disord; 2023 Oct; 25(5):. PubMed ID: 37923553
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
